MODERIL Drug Patent Profile
✉ Email this page to a colleague
When do Moderil patents expire, and when can generic versions of Moderil launch?
Moderil is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in MODERIL is rescinnamine. There is one drug master file entry for this compound. Additional details are available on the rescinnamine profile page.
Summary for MODERIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 33 |
Patent Applications: | 1,184 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MODERIL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for MODERIL
US Patents and Regulatory Information for MODERIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | MODERIL | rescinnamine | TABLET;ORAL | 010686-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | MODERIL | rescinnamine | TABLET;ORAL | 010686-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |